Key Takeaways:
Multidisciplinary care involves a team of specialists reviewing your case before treatment.
It prevents conflicting advice and unnecessary procedures.
Studies show it can improve survival rates by up to 40%.
Renova Hospitals utilises tumour boards for all complex cases.
What is multidisciplinary cancer care, and why does it matter?
Multidisciplinary cancer care is a coordinated treatment approach where a team of specialists (oncologists, surgeons, pathologists) reviews a patient's case together to define the best treatment plan. Think of it as having your entire oncology team, medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists, genetic counselors, and nurses, reviewing your case together before treatment starts.
The goal is simple: make the right cancer treatment decision first, based on your complete medical picture.
Why is team-based cancer care better than seeing one doctor at a time?
Cancer treatment isn't one-size-fits-all. Two patients with the same cancer diagnosis may need completely different treatments based on:
Tumour biology and genetic mutations
Cancer stage at diagnosis
Existing health conditions
Personal priorities like fertility, work, or family
Research proves multidisciplinary cancer care saves lives. Studies of tens of thousands of cancer patients found:
40% lower mortality risk with multidisciplinary team (MDT) care
Faster treatment initiation compared to traditional care
Better overall survival rates
Treatment plan changes in 26-29% of cases after tumour board review
No single specialist can make these complex decisions alone.
How does a multidisciplinary cancer team improve my treatment outcomes?
When your case goes through a tumour board or multidisciplinary cancer clinic, several critical improvements happen:
Impact of MDT on Cancer Survival
Feature | Standard Care (Fragmented) | Multidisciplinary Team (MDT) Care |
Decision Making | A single doctor makes decisions in isolation. | The Tumour Board of surgeons, oncologists, and pathologists reviews the case together. |
Treatment Accuracy | Risk of redundant procedures or outdated sequencing. | Treatment plans are modified in 26–29% of cases to improve accuracy. |
Time to Treatment | Often delayed due to sequential referrals (Doctor A $\rightarrow$ Doctor B). | Faster initiation due to parallel coordination and unified scheduling. |
Survival Outcomes | Baseline survival rates. | 40% lower mortality risk and significantly improved overall survival. |
Patient Experience | High stress; patients coordinate their own appointments. | Low stress; Patient Navigators handle logistics and support. |
Research on liver cancer patients showed that those receiving multidisciplinary cancer care had significantly lower cancer-related death rates than those without MDT involvement.
What are the risks of not having coordinated cancer care?
Many cancer patients experience fragmented cancer care that causes delays and stress:
Cancer screening at one centre
Biopsy at another facility
Cancer surgery scheduled before complete cancer staging
Oncology referral after surgery
Radiation oncology consult added later
Cancer support services are addressed last or never
Without care coordination, your cancer journey becomes longer, more stressful, and medically suboptimal.
Is multidisciplinary cancer care only for advanced or late-stage cancer?
No. This is a common misconception about cancer care coordination.
Team-based cancer care benefits patients at every stage:
Early-stage cancer: Choose the most effective first cancer treatment when initial decisions determine long-term outcomes
Intermediate cancer stages: Balance cancer cure with quality of life
Advanced cancer: Personalise therapy and integrate palliative care
Early-stage cancers often benefit most because the first treatment decision shapes your entire cancer treatment plan.
A systematic review and pooled analysis of studies involving tens of thousands of cancer patients revealed that multidisciplinary team-based care was associated with significantly improved overall survival and faster treatment initiation.
Patients managed by MDTs had better overall survival (hazard ratio ~0.60) and shorter time to treatment compared with non-MDT care.
Why doesn't every cancer patient get multidisciplinary care?
The barriers to multidisciplinary cancer care aren't medical; they're structural.
Multidisciplinary cancer clinics require:
Dedicated time from multiple cancer specialists
Coordinated scheduling systems
Patient navigators
Institutional commitment and resources
These clinics appear less efficient by volume metrics despite delivering higher-value cancer care. Rural cancer care and smaller hospitals face even greater access challenges.
Virtual tumour boards are helping bridge gaps, but widespread adoption needs system-level prioritisation.
What questions should I ask my doctor after a cancer diagnosis?
Advocate for coordinated cancer care by asking these essential questions:
Who is coordinating my cancer care? If the answer is "each doctor separately," you may lack proper care coordination.
Will my case be discussed in a tumour board or multidisciplinary meeting? This ensures team-based decision-making for your cancer treatment.
Do my specialists regularly work together for my type of cancer? Experience with your specific cancer type matters enormously.
Are cancer support services available throughout my treatment? You need supportive cancer care from day one, not just at the end.
How does multidisciplinary care fit with modern cancer treatment advances?
Today's cancer treatment is increasingly personalized. Targeted therapies, immunotherapy, and precision radiation require shared expertise across oncology specialities.
As cancer survival rates improve, comprehensive cancer care must also address:
Functional outcomes and quality of life
Long-term side effects management
Emotional and financial well-being
Life after cancer
These aspects require multiple disciplines working together in a multidisciplinary approach.
Several comprehensive cancer centres in India, including Renova Hospitals, now use multidisciplinary tumour boards to review complex cases before cancer treatment begins, reflecting the shift from isolated decision-making to coordinated cancer care.
What is the future of cancer care?
Multidisciplinary cancer care recognises a fundamental truth: while a doctor may deliver one treatment, you live with all of them.
Modern oncology demands collaboration. Cancer affects more than just the tumour, and cancer care must reflect that reality.
Multidisciplinary cancer care is no longer optional, it's the foundation of safe, effective, and patient-centred cancer treatment.
Cancer patients are beginning to expect nothing less.